Stay updated on Chemoradiotherapy +/- Pembrolizumab in Cervical Cancer Clinical Trial
Sign up to get notified when there's something new on the Chemoradiotherapy +/- Pembrolizumab in Cervical Cancer Clinical Trial page.

Latest updates to the Chemoradiotherapy +/- Pembrolizumab in Cervical Cancer Clinical Trial page
- CheckyesterdayChange DetectedThis update reflects a background change to the ClinicalTrials.gov page revision/version number, with no visible change to the study’s substantive content.SummaryDifference0.0%

- Check8 days agoChange DetectedAdded location entries for Valparaiso, Araucania, Moravian-Silesian Region, and State of Vienna, and updated specific city entries to include the corresponding region names and postal codes (e.g., Vienna, State of Vienna, Austria, 1090; Temuco, Araucania, Chile, 4800827; Viña del Mar, Valparaiso, Chile; Ostrava, Moravian-Silesian Region, Czechia, 708 52). These changes replace prior region names (Vienna; Región de la Araucanía; Región de Valparaíso; Moravskoslezský kraj) with the updated regional qualifiers and reflect a revision from v3.5.0 to v3.5.2.SummaryDifference0.5%

- Check15 days agoNo Change Detected
- Check37 days agoChange DetectedNapoli, Italy, 80131 was replaced with Naples, Italy, 80131. The revision indicator changed from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check51 days agoChange DetectedRevision: v3.4.3 is now displayed, replacing the previous v3.4.2.SummaryDifference0.0%

- Check65 days agoChange DetectedThe study status changed from Active, not recruiting to Completed, with the study completion date updated to 2026-02-20 and related dates adjusted accordingly.SummaryDifference0.1%

- Check73 days agoChange DetectedPage revision updated from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Chemoradiotherapy +/- Pembrolizumab in Cervical Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Chemoradiotherapy +/- Pembrolizumab in Cervical Cancer Clinical Trial page.